PMC:7305592 / 696-1617 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/7305592","sourcedb":"PMC","sourceid":"7305592","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7305592","text":"We conducted a structured telephone interview study in six hospitals across the Netherlands, one academic and five non-academic hospitals, between February 2017 and November 2019. We included 118 relatives of deceased patients diagnosed with metastatic lung cancer who started a systemic treatment as part of usual care (chemotherapy, immunotherapy or targeted therapy with tyrosine kinase inhibitors (TKIs) and who completed a questionnaire on their treatment goals before the start of treatment and when treatment was finished. We asked the relatives about the achievement of patients’ treatment goals and relatives’ satisfaction with the choice to start treatment. This study is part of a larger study in which 266 patients with metastatic lung cancer participated who started a systemic treatment and reported their treatment goals before start of the treatment and the achievement of these goals after the treatment.","tracks":[]}